These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
268 related items for PubMed ID: 8401361
1. Unrelated donor BMT for Wiskott-Aldrich syndrome. Lenarsky C, Weinberg K, Kohn DB, Parkman R. Bone Marrow Transplant; 1993 Aug; 12(2):145-7. PubMed ID: 8401361 [Abstract] [Full Text] [Related]
2. CD6+ T cell depleted allogeneic bone marrow transplantation from genotypically HLA nonidentical related donors. Soiffer RJ, Mauch P, Fairclough D, Alyea E, Anderson K, Fisher D, Freedman A, Bartlett-Pandite L, Robertson M, Schlossman R, Gollob J, Marcus K, Murray C, Kuhlman C, Freeman A, Nadler L, Ritz J. Biol Blood Marrow Transplant; 1997 Apr; 3(1):11-7. PubMed ID: 9209736 [Abstract] [Full Text] [Related]
3. Allogeneic hemopoietic stem cell transplantation (HSCT) for Wiskott-Aldrich syndrome: a report of the Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON). Muñoz A, Olivé T, Martinez A, Bureo E, Maldonado MS, Diaz de Heredia C, Sastre A, Gonzalez-Vicent M, Spanish Working Party for Blood and Marrow Transplantation in Children (GETMON). Pediatr Hematol Oncol; 2007 Sep; 24(6):393-402. PubMed ID: 17710656 [Abstract] [Full Text] [Related]
4. Unrelated bone marrow transplantation in a Wiskott-Aldrich syndrome patient sharing two HLA-extended haplotypes with the donor. La Nasa G, Pizzati A, Ledda A, Vacca A, Arras M, Contu L. Haematologica; 1996 Sep; 81(2):178-81. PubMed ID: 8641653 [Abstract] [Full Text] [Related]
6. [Allogeneic bone marrow transplantation in children from related donors other than HLA-identical siblings]. Morimoto T, Hattori K, Yabe H, Yabe M, Hinohara T, Shimizu T, Matsumoto M, Hagihara M, Tsuji K, Kato S. Rinsho Ketsueki; 1998 Sep; 39(9):631-9. PubMed ID: 9796395 [Abstract] [Full Text] [Related]
7. Allogeneic bone marrow transplantation for children with histiocytic disorders: use of TBI and omission of etoposide in the conditioning regimen. Hale GA, Bowman LC, Woodard JP, Cunningham JM, Benaim E, Horwitz EM, Heslop HE, Krance RA, Leung W, Shearer PD, Handgretinger R. Bone Marrow Transplant; 2003 Jun; 31(11):981-6. PubMed ID: 12774048 [Abstract] [Full Text] [Related]
9. Stem cell transplantation for the Wiskott-Aldrich syndrome: a single-center experience confirms efficacy of matched unrelated donor transplantation. Pai SY, DeMartiis D, Forino C, Cavagnini S, Lanfranchi A, Giliani S, Moratto D, Mazza C, Porta F, Imberti L, Notarangelo LD, Mazzolari E. Bone Marrow Transplant; 2006 Nov; 38(10):671-9. PubMed ID: 17013426 [Abstract] [Full Text] [Related]
10. The putative role of HLA-C recognition in graft versus host disease (GVHD) and graft rejection after unrelated bone marrow transplantation (BMT). Bishara A, Amar A, Brautbar C, Condiotti R, Lazarovitz V, Nagler A. Exp Hematol; 1995 Dec; 23(14):1667-75. PubMed ID: 8542963 [Abstract] [Full Text] [Related]
11. Association of donor-derived host-reactive cytolytic and helper T cells with outcome following alternative donor T cell-depleted bone marrow transplantation. Keever-Taylor CA, Passweg J, Kawanishi Y, Casper J, Flomenberg N, Baxter-Lowe LA. Bone Marrow Transplant; 1997 May; 19(10):1001-9. PubMed ID: 9169644 [Abstract] [Full Text] [Related]
12. Non-total body irradiation containing preparative regimen in alternative donor bone marrow transplantation for severe aplastic anemia. Lee JH, Choi SJ, Lee JH, Lee YS, Seol M, Ryu SG, Lee JS, Kim WK, Lee KH. Bone Marrow Transplant; 2005 Apr; 35(8):755-61. PubMed ID: 15735661 [Abstract] [Full Text] [Related]
13. Prevention of graft-versus-host disease in high risk patients by depletion of CD4+ and reduction of CD8+ lymphocytes in the marrow graft. Herrera C, Torres A, García-Castellano JM, Roman J, Martin C, Serrano J, Falcon M, Alvarez MA, Gomez P, Martinez F. Bone Marrow Transplant; 1999 Mar; 23(5):443-50. PubMed ID: 10100557 [Abstract] [Full Text] [Related]
14. CD8+ T-cell-depleted, matched unrelated donor, allogeneic bone marrow transplantation for advanced AML using busulfan-based preparative regimens. Kalaycio M, Rybicki L, Pohlman B, Sobecks R, Ball E, Cook D, Andresen S, Kuczkowski E, Bolwell B. Bone Marrow Transplant; 2005 Feb; 35(3):247-52. PubMed ID: 15580282 [Abstract] [Full Text] [Related]
16. Unrelated donor bone marrow transplantation for children with severe aplastic anemia: minimal GVHD and durable engraftment with partial T cell depletion. Bunin N, Aplenc R, Iannone R, Leahey A, Grupp S, Monos D, Pierson G. Bone Marrow Transplant; 2005 Feb; 35(4):369-73. PubMed ID: 15640818 [Abstract] [Full Text] [Related]
17. Prevention of graft-versus-host disease with anti-CD5 ricin A chain immunotoxin after CD3-depleted HLA-nonidentical marrow transplantation in pediatric leukemia patients. Przepiorka D, Chan KW, Champlin RE, Culbert SJ, Petropoulos D, Ippoliti C, Khouri I, Huh YO, Vreisendorp H, Deisseroth AB. Bone Marrow Transplant; 1995 Dec; 16(6):737-41. PubMed ID: 8750262 [Abstract] [Full Text] [Related]
18. The role of thiotepa in allogeneic bone marrow transplantation for genetic diseases. Rosales F, Peylan-Ramu N, Cividalli G, Varadi G, Or R, Naparstek E, Slavin S, Nagler A. Bone Marrow Transplant; 1999 May; 23(9):861-5. PubMed ID: 10338039 [Abstract] [Full Text] [Related]
20. Allogeneic hematopoietic cell transplantation from alternative donors in children with myelodysplastic syndrome: is that an alternative? Kalwak K, Wójcik D, Gorczyńska E, Toporski J, Turkiewicz D, Slociak M, Ussowicz M, Pajdosz K, Socha P, Chybicka A. Transplant Proc; 2004 Jun; 36(5):1574-7. PubMed ID: 15251388 [Abstract] [Full Text] [Related] Page: [Next] [New Search]